Universal Prophylaxis Versus Pre-emptive Therapy With Posaconazole Post-Lung Transplant
Clinical trial NCT03561415 · UNKNOWN
Trial details
- NCT number
- NCT03561415
- Sponsor
- Bayside Health
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-02
- Primary completion
- 2020-09-30
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.